Next Article in Journal
Severe Raynaud Syndrome Induced by Adjuvant Interferon Alfa in Metastatic Melanoma
Previous Article in Journal
BONUS 5: 5th Annual Bone and The Oncologist New Updates
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Radiation Recall Dermatitis with Azithromycin

Department of Radiation Oncology, London Regional Cancer Program, 790 Commissioners Road East, London, ON N6A 4L6, Canada
Curr. Oncol. 2010, 17(4), 119-121; https://doi.org/10.3747/co.v17i4.488
Submission received: 3 June 2010 / Revised: 3 July 2010 / Accepted: 10 July 2010 / Published: 1 August 2010

Abstract

Radiation recall is a well-known phenomenon that involves the “recall” of an acute inflammatory reaction in a previously irradiated region after administration of certain drugs. The most common type of radiation recall is radiation recall dermatitis, which involves the reoccurrence of an acute inflammatory skin reaction in previously irradiated skin. Most radiation recall reactions are attributable to chemotherapeutic agents. One previously reported case of radiation recall dermatitis occurred after administration of an antibiotic. The present case report is the second of radiation recall dermatitis involving an antibiotic: azithromycin.
Keywords: radiation recall dermatitis; azithromycin radiation recall dermatitis; azithromycin

Share and Cite

MDPI and ACS Style

Vujovic, O. Radiation Recall Dermatitis with Azithromycin. Curr. Oncol. 2010, 17, 119-121. https://doi.org/10.3747/co.v17i4.488

AMA Style

Vujovic O. Radiation Recall Dermatitis with Azithromycin. Current Oncology. 2010; 17(4):119-121. https://doi.org/10.3747/co.v17i4.488

Chicago/Turabian Style

Vujovic, O. 2010. "Radiation Recall Dermatitis with Azithromycin" Current Oncology 17, no. 4: 119-121. https://doi.org/10.3747/co.v17i4.488

Article Metrics

Back to TopTop